Gene Therapy for Kids’ Deadly Disease Wins Broader FDA Approval

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 50%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Sarepta Therapeutics Inc.’s gene therapy received expanded US approval to include more children with a deadly muscle disease, expanding the market for a controversial treatment that still hasn’t proved its benefit in clinical trials.

Gene Therapy for Kids’ Deadly Disease Wins Broader FDA ApprovalUnited Airlines Plane Turns Back After Engine Piece Falls OffHackers Auction Off Stolen LendingTree Consumers’ InformationThe Hedge Fund Veterans Delivering Capital Relief to Banks, With an ESG TwistSEC Chair Gensler Says UK, Other Markets Should Move to Faster Currency SettlementMortgage Rates in the US Decline to a Two-Month Low of 6.

4% in AprilThe Daily Chase: French election anxiety continues to weigh down European sharesBOE Rate-Cut Signal Poised to Hand ‘Feel-Good Factor’ to StarmerUkraine Anti-Graft Chief Summoned to Parliament, Fails to ShowLe Pen Party Holds on to Lead in French Vote, Harris Poll ShowsPutin Says Russia May Send North Korea High-Precision WeaponsVenezuela Opposition Spurns Pact to Recognize July Vote ResultsChina Isn’t Worried About Who Will Win US Presidential Race, Spies SayBerenberg Says French...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in HEALTH

Health Health Latest News, Health Health Headlines